BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34958500)

  • 1. Unravelling undifferentiated soft tissue sarcomas: insights from genomics.
    Hames-Fathi S; Nottley SWG; Pillay N
    Histopathology; 2022 Jan; 80(1):109-121. PubMed ID: 34958500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genomics of undifferentiated sarcoma of soft tissue: Progress, challenges and opportunities.
    Steele CD; Pillay N
    Semin Cancer Biol; 2020 Apr; 61():42-55. PubMed ID: 31866474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undifferentiated and dedifferentiated soft tissue neoplasms: Immunohistochemical surrogates for differential diagnosis.
    Thway K; Fisher C
    Semin Diagn Pathol; 2021 Nov; 38(6):170-186. PubMed ID: 34602314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleomorphic Sarcomas: The State of the Art.
    Carvalho SD; Pissaloux D; Crombé A; Coindre JM; Le Loarer F
    Surg Pathol Clin; 2019 Mar; 12(1):63-105. PubMed ID: 30709449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in the genomics of soft tissue sarcomas.
    Conley AP; Trent J; Zhang W
    Curr Opin Oncol; 2008 Jul; 20(4):395-9. PubMed ID: 18525334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
    Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
    Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current challenges and practical aspects of molecular pathology for bone and soft tissue tumors.
    de Álava E
    Virchows Arch; 2024 Feb; 484(2):353-367. PubMed ID: 38228904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing biomarkers for soft tissue sarcomas.
    Czarnecka AM; Chmiel P; Błoński P; Rutkowski P
    Expert Rev Anticancer Ther; 2024 Jun; 24(6):407-421. PubMed ID: 38682679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics.
    Gibault L; Pérot G; Chibon F; Bonnin S; Lagarde P; Terrier P; Coindre JM; Aurias A
    J Pathol; 2011 Jan; 223(1):64-71. PubMed ID: 21125665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refinements in Sarcoma Classification in the Current 2013 World Health Organization Classification of Tumours of Soft Tissue and Bone.
    Jo VY; Doyle LA
    Surg Oncol Clin N Am; 2016 Oct; 25(4):621-43. PubMed ID: 27591490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undifferentiated pleomorphic sarcoma with co-existence of KRAS/PIK3CA mutations.
    Li B; Li L; Li X; Wang Y; Xie Y; Liu C; Li F
    Int J Clin Exp Pathol; 2015; 8(7):8563-7. PubMed ID: 26339434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High IGF2 and FGFR3 are associated with tumour progression in undifferentiated pleomorphic sarcomas, but EGFR and FGFR3 mutations are a rare event.
    Rüping K; Altendorf-Hofmann A; Chen Y; Kampmann E; Gibis S; Lindner L; Katenkamp D; Petersen I; Knösel T
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1315-22. PubMed ID: 24804818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
    Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F
    J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives.
    Sbaraglia M; Bellan E; Dei Tos AP
    Pathologica; 2021 Apr; 113(2):70-84. PubMed ID: 33179614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel fusion sarcomas including targetable NTRK and ALK.
    Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
    Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma.
    Öfverholm I; Wallander K; Haglund C; Chellappa V; Wejde J; Gellerbring A; Wirta V; Renevey A; Caceres E; Tsagkozis P; Mayrhofer M; Papakonstantinou A; Linder-Stragliotto C; Bränström R; Larsson O; Lindberg J; Lin Y; Haglund de Flon F
    Clin Cancer Res; 2024 Jun; 30(12):2647-2658. PubMed ID: 38573684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pathology of soft tissue sarcomas].
    Schmidt D
    Radiologe; 1992 Dec; 32(12):579-83. PubMed ID: 1492148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern morphological diagnosis and current classification of soft tissue sarcomas].
    Katenkamp D; Katenkamp K
    Chirurg; 2009 Mar; 80(3):186-93. PubMed ID: 19172240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sarcomas: from pathology to molecular pathology and new nosology].
    Coindre JM
    Bull Acad Natl Med; 2015 Jan; 199(1):33-8; discussion 39. PubMed ID: 27236876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical correlates of recurrent genetic alterations in sarcomas.
    Anderson WJ; Hornick JL
    Genes Chromosomes Cancer; 2019 Feb; 58(2):111-123. PubMed ID: 30382607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.